US FDA grants fast track designation to Pfizer’s ervogastat/clesacostat combination to treat NASH Read more
Pfizer/BioNTech say three COVID shots elicit good response in children under five years of age Read more
Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small cell lung cancer Read more